Cargando…
Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus
This study evaluated whether metformin might reduce esophageal cancer risk. Patients with type 2 diabetes mellitus diagnosed during 1999–2005 were recruited from the reimbursement database of Taiwan's National Health Insurance. Those newly treated with metformin (n = 288013, “ever users of metf...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386648/ https://www.ncbi.nlm.nih.gov/pubmed/27861146 http://dx.doi.org/10.18632/oncotarget.13390 |